Severe Acute Respiratory Syndrome (SARS) is a disease that first appeared in humans in November 2002. Infection initially brings flu-like symptoms including fever and fatigue, but it then attacks ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Australian scientists developed a novel antiviral that targets the SARS-CoV-2 PLpro enzyme, showing strong preclinical ...

“In general, transmission in Europe is driven by suboptimal vaccination coverage for measles in a number of EU/EEA countries.

Otto and co-author Sean Edgerton, a PhD student focused on genomics and infectious diseases at the University of British ...

The newest one to make people sick causes COVID-19, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first record of illness linked to SARS-CoV-2 was in China in ...

No increased risk for new-onset T2D was found after mild SARS-CoV-2 infection in a multiethnic Asian cohort during the Omicron or Delta wave, particularly among fully vaccinated individuals.

SARS (severe acute respiratory syndrome) and MERS (Middle East respiratory syndrome) are serious infectious respiratory diseases that are caused by members of a class of viruses known as coronaviruses ...

In mechanically ventilated patients with ARDS, the treatment effect of neuromuscular blockade on mortality likely varies with respiratory elastance.

VQ Biomedical, a startup born at Duke University, has secured $5 million in funding to advance a device it says will treat ...

A study presented at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute ...